A case of non-severe COVID-19 complicated by pulmonary embolism

Yuto Akiyama; Kohei Horiuchi; Yasushi Kondo; Hiroki Kabata; Makoto Ishii; Koichi Fukunaga

doi:10.1002/rcr2.622

A case of non-severe COVID-19 complicated by pulmonary embolism

Yuto Akiyama, Kohei Horiuchi, Yasushi Kondo, Hiroki Kabata, Makoto Ishii, Koichi Fukunaga

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID-19 is pneumonia, which can progress to acute respiratory distress syndrome and respiratory failure. Recent studies have reported that COVID-19 is often accompanied by coagulopathy, and a significant number of patients with severe or critical COVID-19 develop concomitant thrombosis, including pulmonary embolism (PE). However, there are limited reports of the incidence of PE in non-severe COVID-19 patients. Here, we report a case of non-severe COVID-19 complicated by PE, which indicates that the possibility of PE should consistently be considered, even in non-severe cases of COVID-19 without any risk of thrombosis.

Original language	English
Article number	e00622
Journal	Respirology Case Reports
Volume	8
Issue number	7
DOIs	https://doi.org/10.1002/rcr2.622
Publication status	Published - 2020 Oct 1

Keywords

COVID-19
D-dimer
Padua prediction score
SARS-CoV-2
pulmonary embolism

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1002/rcr2.622

Fingerprint Dive into the research topics of 'A case of non-severe COVID-19 complicated by pulmonary embolism'. Together they form a unique fingerprint.

Cite this

@article{08be20ea7a3d4a67b60a47d53d6e6ba3,

title = "A case of non-severe COVID-19 complicated by pulmonary embolism",

abstract = "Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID-19 is pneumonia, which can progress to acute respiratory distress syndrome and respiratory failure. Recent studies have reported that COVID-19 is often accompanied by coagulopathy, and a significant number of patients with severe or critical COVID-19 develop concomitant thrombosis, including pulmonary embolism (PE). However, there are limited reports of the incidence of PE in non-severe COVID-19 patients. Here, we report a case of non-severe COVID-19 complicated by PE, which indicates that the possibility of PE should consistently be considered, even in non-severe cases of COVID-19 without any risk of thrombosis.",

keywords = "COVID-19, D-dimer, Padua prediction score, SARS-CoV-2, pulmonary embolism",

author = "Yuto Akiyama and Kohei Horiuchi and Yasushi Kondo and Hiroki Kabata and Makoto Ishii and Koichi Fukunaga",

note = "Funding Information: We would like to thank all the members of the Keio COVID-19 Lifesaving Team, the Keio Donner Project Team, and the staff who supported us at the Keio University Hospital.",

year = "2020",

month = oct,

day = "1",

doi = "10.1002/rcr2.622",

language = "English",

volume = "8",

journal = "Respirology Case Reports",

issn = "2051-3380",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - A case of non-severe COVID-19 complicated by pulmonary embolism

AU - Akiyama, Yuto

AU - Horiuchi, Kohei

AU - Kondo, Yasushi

AU - Kabata, Hiroki

AU - Ishii, Makoto

AU - Fukunaga, Koichi

N1 - Funding Information: We would like to thank all the members of the Keio COVID-19 Lifesaving Team, the Keio Donner Project Team, and the staff who supported us at the Keio University Hospital.

PY - 2020/10/1

Y1 - 2020/10/1

N2 - Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID-19 is pneumonia, which can progress to acute respiratory distress syndrome and respiratory failure. Recent studies have reported that COVID-19 is often accompanied by coagulopathy, and a significant number of patients with severe or critical COVID-19 develop concomitant thrombosis, including pulmonary embolism (PE). However, there are limited reports of the incidence of PE in non-severe COVID-19 patients. Here, we report a case of non-severe COVID-19 complicated by PE, which indicates that the possibility of PE should consistently be considered, even in non-severe cases of COVID-19 without any risk of thrombosis.

AB - Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID-19 is pneumonia, which can progress to acute respiratory distress syndrome and respiratory failure. Recent studies have reported that COVID-19 is often accompanied by coagulopathy, and a significant number of patients with severe or critical COVID-19 develop concomitant thrombosis, including pulmonary embolism (PE). However, there are limited reports of the incidence of PE in non-severe COVID-19 patients. Here, we report a case of non-severe COVID-19 complicated by PE, which indicates that the possibility of PE should consistently be considered, even in non-severe cases of COVID-19 without any risk of thrombosis.

KW - COVID-19

KW - D-dimer

KW - Padua prediction score

KW - SARS-CoV-2

KW - pulmonary embolism

UR - http://www.scopus.com/inward/record.url?scp=85090287585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090287585&partnerID=8YFLogxK

U2 - 10.1002/rcr2.622

DO - 10.1002/rcr2.622

M3 - Article

AN - SCOPUS:85090287585

VL - 8

JO - Respirology Case Reports

JF - Respirology Case Reports

SN - 2051-3380

IS - 7

M1 - e00622

ER -